Current Lipid Management Guidelines in Atherosclerotic Cardiovascular Disease

Al-Taweel, Muneera and AlAnazi, Faisal and Al-Mukhaylid, Sarah and Alkhashram, Abdulwahab and Alkhazmari, Gousay and Abushullaih, Faisal (2022) Current Lipid Management Guidelines in Atherosclerotic Cardiovascular Disease. Asian Journal of Cardiology Research, 7 (2). pp. 1-8.

[thumbnail of 97-Article Text-157-1-10-20220825.pdf] Text
97-Article Text-157-1-10-20220825.pdf - Published Version

Download (456kB)


The use of coronary artery calcium (CAC) score to reclassify risk individuals at either borderline or intermediate risk, for whom the danger of statin therapy is unknown, is another significant addition to the 2018 recommendations. Increased risk of recurrent cardiovascular (CV) events is linked to having established atherosclerotic cardiovascular disease (ASCVD). Many modifiable risk factors for cardiovascular disease have been connected in the literature, including blood pressure, low-density lipoprotein (LDL), high-density lipoprotein (HDL), glucose intolerance, and smoking. High dose statins and strict adherence to dietary and lifestyle changes have been shown to reduce the risk of coronary events, with the advent of newer lipid-lowering medications, statins may one day become obsolete.

Item Type: Article
Subjects: Euro Archives > Medical Science
Depositing User: Managing Editor
Date Deposited: 18 Feb 2023 06:40
Last Modified: 14 Mar 2024 03:40

Actions (login required)

View Item
View Item